Welcome to our dedicated page for Roth CH Acquisition Co. Warrant SEC filings (Ticker: USCTW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Roth CH Acquisition Co. Warrant's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Roth CH Acquisition Co. Warrant's regulatory disclosures and financial reporting.
Roth CH Acquisition Co. (USCTW) reported condensed interim results for the period ended June 30, 2025 showing limited cash of $9,728 and a working capital deficit of $1,545,956, raising substantial doubt about the company’s ability to continue as a going concern.
The filing shows significant equity activity: 45,203,220 Class A ordinary shares and 75,000 Class B ordinary shares outstanding at June 30, 2025 (versus 5,836,553 Class A at December 31, 2024). The company previously raised gross IPO proceeds of $230,000,000 from Units and $10,750,000 from private placement warrants. Related-party financing under a 2023 Promissory Note was $0 outstanding at June 30, 2025 (versus $1,109,412 at December 31, 2024). Deferred legal fees of $234,849 are included in accounts payable.
FAQ
What is the current stock price of Roth CH Acquisition Co. Warrant (USCTW)?
